AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Nov 1, 2017
30071_dirs_2017-11-01_e7183ff3-8f9f-4ab2-b8d9-e4983910cfac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-10-31
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-31 | ResMed Common Stock | M | 3300 | $33.70 | Acquired | 232732 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-31 | ResMed Common Stock Options | $33.70 | M | 3300 | Disposed | 2017-11-11 | ResMed Common Stock (3300) | Direct |
Footnotes
F1: The transaction represents an exercise and hold of expiring options.
F2: Represents date options first became exercisable. Options vest 1/4 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29